NCT07591311

Brief Summary

The goal of this observational study is to learn about the effectiveness of different locoregional anesthesia techniques, particularly the Quadro-Iliac Plane (QIP) block, in patients undergoing total hip arthroplasty. The main question it aims to answer is: Does the QIP block improve postoperative recovery and pain control compared to other routinely used locoregional anesthesia techniques in patients undergoing hip replacement surgery? Participants undergoing hip arthroplasty as part of their standard clinical care will receive one of the locoregional anesthesia techniques already in use at the hospital (including QIP block, fascia iliaca block, PENG block, or others, according to anesthesiologist choice). Postoperative outcomes will be collected prospectively, including quality of recovery (QoR-15 at 24 hours), pain scores at rest and during movement at predefined time points up to 48 hours, analgesic consumption, time to first analgesic request, time to mobilization, and occurrence of complications.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
17mo left

Started May 2026

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
May 2026Nov 2027

Study Start

First participant enrolled

May 1, 2026

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 4, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 15, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

1.1 years

First QC Date

May 4, 2026

Last Update Submit

May 18, 2026

Conditions

Keywords

regional anesthesiahiphip fractureQIP

Outcome Measures

Primary Outcomes (1)

  • Quality of Recovery (QoR)-15 score

    The Quality of Recovery-15 (QoR-15) is a validated patient-reported outcome measure designed to assess the quality of postoperative recovery across multiple dimensions of physical and psychological well-being. The questionnaire consists of 15 items, each scored on an 11-point numerical scale, resulting in a total score ranging from: Minimum score: 0 → extremely poor quality of recovery Maximum score: 150 → excellent quality of recovery Higher QoR-15 scores indicate a better postoperative recovery experience. The questionnaire evaluates five key domains: Pain Physical comfort Physical independence Psychological support Emotional state

    24 hours postoperatively

Secondary Outcomes (4)

  • Postoperative Pain

    0-2-4-6-8-12-24-48 hours after surgery

  • First analgesia request

    up to 48 hours

  • First mobilization

    24 hours postoperatively

  • Complications

    up to 48 hours

Study Arms (1)

QIP

Quadro-Iliac Plane Block

Procedure: Fascia iliaca block (FIB)

Interventions

Fascia Iliaca Block

QIP

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing hip arthroplasty surgery, either elective or for a proximal femoral fracture

You may qualify if:

  • Age ≥ 18 years
  • Patients undergoing hip arthroplasty surgery, either elective or for a proximal femoral fracture
  • Expected postoperative hospital stay ≥ 24 hours
  • ASA physical status I-III
  • Neuraxial and/or locoregional anesthesia according to standard clinical practice
  • Provision of informed consent to participate in the study

You may not qualify if:

  • Absence of informed consent
  • Contraindications to locoregional and/or spinal anesthesia
  • Allergy to local anesthetic agents
  • Cognitive impairment preventing reliable assessment of outcomes
  • Coagulation disorders and/or platelet abnormalities
  • Antiplatelet or anticoagulant therapy that contraindicates spinal anesthesia
  • Presence of localized infection or sepsis at the sites to be treated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Crotone Hospital

Crotone, Italy

RECRUITING

Crotone Hospital

Crotone, Italy

RECRUITING

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Central Study Contacts

Tommaso Sorrentino, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 4, 2026

First Posted

May 15, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

May 22, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations